E-clinical Solution Software Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1524 | Report Format : | Status : Upcoming |

Abstract

Global E-clinical Solution Software Market: Overview

The e-clinical solutions are helpful in collecting the clinical research data and managing it using advanced technology. The different types of e-clinical solution software that are available in the global market are web-based solution software, cloud-based solution software, and licensed enterprise solution software. In the coming years, the market will develop cloud-based e-clinical solution software that will increase its demand.

Global E-clinical Solution Software Market: Segmentation

The e-clinical solution software market is globally segmented into its product, delivery mode, clinical trial phase, and end user. On the basis of product, the global market is segregated into electronic data capture and clinical data management systems, clinical analytics platform, clinical data integration platform, safety solutions, regulatory information management solutions, clinical trial management systems, randomization and trial supply management, electronic clinical outcome assessment, electronic trail master files, and others. Based on the delivery mode, the market is categorized into cloud-based, web-hosted, and licensed enterprise. Depending on the clinical trial phase, the market is divided into Phase I, II, III, and IV. The different end-users that utilize in the e-clinical solution are contract research organizations, medical device manufacturers, academic research institutions, pharmaceutical and biopharmaceutical companies, consulting service companies, and hospitals.

Global E-clinical Solution Software Market: Growth Factors

The increasing demand for the discovery of new drugs with the help of clinical trials and research and development expects to augment the growth of the global e-clinical solution software market. The market is also driven due to the growing need for standardization of data and efficient data management. The e-clinical solution software provides the following benefits such as improved productivity of drugs and reduced time during clinical trials coaxes several end users to adopt latest technologies. The top end-users in the global e-clinical solution software market are the healthcare sector, clinical research organizations (CROs), and the pharmaceutical sector. The pharmaceutical sector will dominate the global market as a number of market players are focusing on developing an improved and new line of drugs.

Global E-clinical Solution Software Market: Regional Analysis

The global e-clinical solution market is diversified into regions such as Asia Pacific, North America, Europe, and Rest of the World. North America dominates the overall market owing to the increasing preference of institutes and organizations toward advancement in the technology. Rise in the number of clinical trials, the increasing investments made by the governments to digitize the clinical solutions, and growth of pharmaceutical companies are some factors that expect to make a major impact on the e-clinical software market in the North American region. Asia Pacific will show a steady progress in the global market owing to the huge patient base. The medical tourism industry has emerged in this region and the maturing clinical research organizations (CROs) estimate to have a positive influence on the regional market growth.

Global E-clinical Solution Software Market: Competitive Players

Some of the key market players that are involved in the e-clinical solution software market include Medidata Solutions, Inc., BioClinica, Inc., DATATRAK International, Inc., MaxisIT Inc., eClinical Solutions, Inc., OmniComm Systems, Inc., PAREXEL International Corporation, CRF Health, ERT, Bio-Optronics, Inc., and Merge Healthcare Incorporated.

Global E-clinical Solution Software Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports